New Delhi, July 23 (IANS) India’s pharma and healthcare sector recorded 65 deals worth $13.9 billion in the second quarter of 2026, a report said on Thursday.Despite lower activity, overall deal values remained resilient, the report from Grant Thornton Bharat said. Excluding a $11.8 billion deal which was the largest overseas purchase by an Indian pharmaceutical company, overall deal values still rose 12 per cent over the previous quarter.”The quarter reflects a clear strategic shift in India’…
Latest Bhanu Prakash Kalmath S.J. News & Updates
New Delhi, April 29 (IANS) India’s pharma and healthcare sector recorded 78 deals worth $1.9 billion in Q1 2026, with deal volumes holding steady even as overall values moderated in the absence of large‑ticket transactions, a report said on Wednesday.The report from Grant Thornton Bharat said mergers and acquisitions accounted for 30 deals worth $915 million during the quarter, with volumes remaining broadly stable and values moderating about 40 per cent sequentially.The moderation in the de…